PTC Therapeutics Inc (PTCT) Insider Trading
- $31,673,582.00
- $179,522,421.48
- April 6, 2026
- Mark Elliott Boulding
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 3, 2020 | Insider | 6,194 | $56.50 | Sell | $349,961.00 | |
| Nov. 2, 2020 | CEO | 50,000 | $53.66 | Sell | $2,683,000.00 | |
| Oct. 16, 2020 | Director | 5,000 | $51.29 | Sell | $256,450.00 | |
| Oct. 6, 2020 | CAO | 2,500 | $50.08 | Sell | $125,200.00 | |
| Oct. 6, 2020 | CEO | 124,351 | $50.12 | Sell | $6,232,472.12 | |
| July 15, 2020 | CEO | 100,000 | $55.70 | Sell | $5,570,000.00 | |
| July 7, 2020 | VP | 30,625 | $55.12 | Sell | $1,688,050.00 | |
| July 6, 2020 | CAO | 3,288 | $53.70 | Sell | $176,565.60 | |
| June 29, 2020 | CFO | 2,581 | $52.50 | Sell | $135,502.50 | |
| May 20, 2020 | CEO | 33,788 | $50.00 | Sell | $1,689,400.00 | |
| May 5, 2020 | CEO | 109,928 | $50.34 | Sell | $5,533,775.52 | |
| April 20, 2020 | Director | 17,900 | $51.04 | Sell | $913,616.00 | |
| April 17, 2020 | Director | 2,100 | $50.16 | Sell | $105,336.00 | |
| April 17, 2020 | CAO | 2,145 | $50.00 | Sell | $107,250.00 | |
| April 3, 2020 | CAO | 787 | $44.31 | Sell | $34,871.97 | |
| Jan. 23, 2020 | CEO | 423 | $53.25 | Sell | $22,524.75 | |
| Jan. 23, 2020 | CFO | 330 | $53.25 | Sell | $17,572.50 | |
| Jan. 23, 2020 | COO | 154 | $53.25 | Sell | $8,200.50 | |
| Jan. 23, 2020 | Insider | 46 | $53.25 | Sell | $2,449.50 | |
| Jan. 7, 2020 | CAO | 13,750 | $50.02 | Sell | $687,775.00 | |
| Jan. 6, 2020 | Insider | 507 | $48.17 | Sell | $24,422.19 | |
| Jan. 6, 2020 | CFO | 321 | $48.17 | Sell | $15,462.57 | |
| Jan. 6, 2020 | COO | 86 | $48.17 | Sell | $4,142.62 | |
| Jan. 6, 2020 | CEO | 1,797 | $48.17 | Sell | $86,561.49 | |
| Dec. 3, 2019 | CEO | 22,463 | $49.43 | Sell | $1,110,346.09 | |
| July 5, 2019 | VP | 15,312 | $44.74 | Sell | $685,058.88 | |
| July 1, 2019 | SVP | 14,059 | $45.14 | Sell | $634,623.26 | |
| July 1, 2019 | VP | 181,667 | $45.00 | Sell | $8,175,015.00 | |
| June 28, 2019 | VP | 77,575 | $45.00 | Sell | $3,490,875.00 | |
| June 28, 2019 | CAO | 988 | $45.00 | Sell | $44,460.00 | |
| June 3, 2019 | COO | 5,490 | $40.38 | Sell | $221,686.20 | |
| March 5, 2019 | Insider | 28,709 | $34.97 | Sell | $1,003,953.73 | |
| Jan. 25, 2019 | Director | 66,225 | $30.20 | Buy | $1,999,995.00 | |
| Jan. 7, 2019 | CEO | 2,512 | $34.75 | Sell | $87,292.00 | |
| Jan. 7, 2019 | Insider | 297 | $34.75 | Sell | $10,320.75 | |
| Jan. 7, 2019 | COO | 83 | $34.75 | Sell | $2,884.25 | |
| June 19, 2018 | EVP | 20,000 | $48.31 | Sell | $966,200.00 | |
| June 1, 2018 | COO | 5,161 | $34.65 | Sell | $178,828.65 | |
| Jan. 5, 2018 | CEO | 2,230 | $18.03 | Sell | $40,206.90 | |
| Jan. 4, 2018 | Insider | 412 | $17.67 | Sell | $7,280.04 | |
| Jan. 4, 2018 | EVP | 77 | $17.67 | Sell | $1,360.59 | |
| May 23, 2017 | Director | 25,000 | $13.49 | Buy | $337,250.00 | |
| Jan. 5, 2017 | EVP | 78 | $11.82 | Sell | $921.96 | |
| March 3, 2016 | Insider | 2,000 | $6.23 | Buy | $12,460.00 | |
| July 6, 2015 | Director | 23,604 | $47.52 | Sell | $1,121,662.08 | |
| June 18, 2015 | Director | 5,000 | $50.13 | Sell | $250,650.00 | |
| June 9, 2015 | CEO | 100,000 | $54.49 | Sell | $5,449,000.00 | |
| June 8, 2015 | Director | 7,000 | $55.66 | Sell | $389,620.00 | |
| June 8, 2015 | VP | 56,849 | $55.04 | Sell | $3,128,968.96 | |
| June 8, 2015 | CEO | 73,700 | $54.91 | Sell | $4,046,867.00 |
Insiders are both buying and selling PTC Therapeutics Inc stock.
The insider traders at PTC Therapeutics Inc are: Mark Elliott Boulding, Stuart Walter Peltz, Christine Marie Utter, Neil Gregory Almstead, Emily Luisa Hill, Eric Pauwels, Matthew B Klein, Allan Steven Jacobson, Mark Rothera, Lee Scott Golden, Stephanie Okey, David P Southwell, Claudia De Oliveira Ri Hirawat, Pierre Gravier, Marcio Souza, Dawn Svoronos, Emma Reeve, Hbm Healthcare Investments (Ca, Jerome B Zeldis, Michael Schmertzler, Shane William Charles Kovacs, Alethia Young, Matthew B. Klein, Adam Koppel, Richard Aldrich, Robert J Spiegel, Robert Spiegel, David Southwell, Michael Kranda, and Michael L Kranda
The most active insider trader at PTC Therapeutics Inc is Mark Elliott Boulding with 34 trades.
Stuart Walter Peltz has sold the most PTC Therapeutics Inc stock with a total value of $85,044,720.20.
Adam Koppel has bought the most PTC Therapeutics Inc stock with a total value of $37,500,000.00.
The most recent insider trade for PTC Therapeutics Inc was on April 6, 2026.
The single biggest insider buy for PTC Therapeutics Inc was from Adam Koppel with a total value of $18,750,000.00 on June 25, 2013.
The single biggest insider sell for PTC Therapeutics Inc was from Stuart Walter Peltz with a total value of $21,253,437.00 on Dec. 7, 2020.
